Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Olema Pharmaceuticals, Inc. (OLMA) had Normalized Income after Taxes of $-53.09M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-53.09M |
|
-- |
|
-- |
|
$57.99M |
|
$-57.99M |
|
$4.90M |
|
$-53.09M |
|
$-53.09M |
|
$-53.09M |
|
$-53.09M |
|
$-53.09M |
|
|
Normalized Income after Taxes |
$-53.09M |
$-57.99M |
|
$-57.87M |
|
102.80M |
|
102.80M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$513.23M |
|
-- |
|
$17.42M |
|
$530.64M |
|
$47.17M |
|
$3.00M |
|
$3.00M |
|
$50.17M |
|
$480.48M |
|
$480.48M |
|
$480.48M |
|
87.33M |
|
| Cash Flow Statement Financials | |
$-45.99M |
|
$4.53M |
|
$45.70M |
|
$48.30M |
|
$52.55M |
|
$4.25M |
|
$10.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.88 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.05% |
|
-11.05% |
|
-10.00% |
|
-10.98% |
|
$5.50 |
|
$-0.45 |
|
$-0.45 |
|